In such cases, serum liver function tests, serology for viral hepatitis, alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and imaging studies with tumor characterization are part of the initial diagnostic workup. This evidence concerns the gene CEACAM5 and viral hepatitis.